Non-opioid pain pill could be game-changer The Federal Drug Administration last month approved Journavx, a new kind of non-addictive pain medication. Doctors say Journavx is an important alternative because the power of opioids helped fuel an overdose epidemic and a surge in fentanyl use. Stepha...
Supreme Court, where justices heard arguments on a case involving the FDA's approval and regulations for the use of mifepristone. Mar 26, 2024 01:56 U.S. Supreme Court to hear arguments on abortion pill mifepristone This week, abortion access returns to the U.S. Supreme Court, nearly...
For more information, visit https://www.dallasnews.com/branded-content/2022/08/26/leanbean-review-legit-fat-burner-for-women-or-diet-pill-scam/. How Appetite Suppressants Work The first thing you need to know about appetite suppressants is how they work. Appetite suppressants reduce your hun...
Breast cancer risk slashed by rainbow diet Breast cancer surgeon accused of operating on women to make money Commensal bacteria go missing in breast cancer Enough evidence exists to link bpa exposure to breast and prostate cancer Five natural compounds that help fight her2 breast cancer Natural compo...
FDA approves new Alzheimer's drug that 'slows progression by 22%' The Food and Drug Administration on Tuesday approved Eli Lilly's Kisunla, a medication that... Moderna signs $176m deal with US to develop bird flu vaccine as infections rise Bird flu pandemic 'unfolding in slow motion' ...
New York doctor indicted for prescribing abortion pill in Louisiana FDA OK's painkiller designed to end opioids' addiction and overdose risk Ugandan nurse dies from Ebola in country's first death from virus in years More Health News Business News Texas Rangers announce new broadcast agreemen...
The Supreme Court issued a unanimous ruling preserving access to the abortion pill mifepristone on Thursday. The justices ruled that the group of anti-abortion rights doctors who sued the FDA did not have the legal grounds to do so. CBS News legal contributor Jessica Levinson breaks down the de...
FDA approves first new non-opioid pain pill in decades The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or overdose linked to drugs like Vicodin and OxyContin. Jan 31, 2025 ...
FDA approves Bimzelx for hidradenitis suppurativa The U.S. Food and Drug Administration has approved UCB's Bimzelx (bimekizumab-bkzx) for the treatment of adults with moderate-to-severe hidradenitis suppurativa. Nov 26, 2024 0 1 Diseases, Conditions, Syndromes New malaria vaccine shows hig...
FDA asks Biden administration to limit nicotine in tobacco products In what appears to be a last-ditch effort to limit the harms of smoking before its term ends, the Biden administration has proposed a rule that would significantly lower the amount of nicotine in tobacco products. Dec 12, 20...